Through the analysis of a tissue microarray of a retrospective cohort (158 HCC patients), the low-SAMD4B-expression samples contained more CD29+CD8+ T cells (Fig. 6j), and the high expression of CD29+CD8+ T cells had a worse prognosis (Fig. 6k). The gene discussed is ITGB1; the disease is hepatocellular carcinoma.